Augmentin Dosing for Adults with Normal Renal Function
For adults with normal renal function, the standard Augmentin dosing is 500 mg every 12 hours or 250 mg every 8 hours for mild to moderate infections, and 875 mg every 12 hours or 500 mg every 8 hours for severe infections or lower respiratory tract infections. 1
Standard Dosing Regimens
Mild to Moderate Infections
- Ear/nose/throat, skin/skin structure, or genitourinary tract infections: 500 mg every 12 hours OR 250 mg every 8 hours 1
- These dosing schedules apply to most community-acquired infections in patients without significant comorbidities 1
Severe Infections
- Severe infections or lower respiratory tract infections: 875 mg every 12 hours OR 500 mg every 8 hours 1
- The higher dose regimen provides enhanced coverage against pathogens with reduced susceptibility 1
Administration Guidelines
- Take Augmentin at the start of a meal to minimize gastrointestinal intolerance 1
- Continue treatment for a minimum of 48-72 hours beyond symptom resolution or evidence of bacterial eradication 1
- For Streptococcus pyogenes infections, treat for at least 10 days to prevent acute rheumatic fever 1
Enhanced Formulations for Resistant Pathogens
High-Dose Extended Release (Augmentin XR)
- Dosing: 2000 mg/125 mg twice daily 2, 3
- Indications: Community-acquired respiratory tract infections caused by drug-resistant Streptococcus pneumoniae (with penicillin MICs ≥2 mcg/mL but ≤4 mcg/mL), beta-lactamase-producing Haemophilus influenzae, or Moraxella catarrhalis 2, 3
- This formulation maintains plasma amoxicillin concentrations above 4 mcg/mL for approximately 49% of the dosing interval, providing enhanced activity against resistant pathogens 3
Special Clinical Scenarios
H. pylori Eradication (Triple Therapy)
- Dosing: 1 gram amoxicillin with 500 mg clarithromycin and 30 mg lansoprazole, all given twice daily for 14 days 1
H. pylori Eradication (Dual Therapy)
- Dosing: 1 gram amoxicillin with 30 mg lansoprazole, both given three times daily for 14 days 1
Clinical Efficacy Evidence
- Augmentin demonstrates approximately 70% success rates for amoxicillin-resistant organisms in urinary tract infections 4
- The combination shows high bacteriological and clinical efficacy in respiratory tract infections over more than 20 years of clinical use 2
- The drug exhibits a low propensity to select resistance mutations, contributing to its sustained clinical utility 2
Common Pitfalls to Avoid
- Do not use the 875 mg dose in patients with severe renal impairment (GFR <30 mL/min), as dose reduction is required 1
- Avoid skipping the meal-time administration, as this significantly increases gastrointestinal side effects 1
- Do not discontinue therapy prematurely when symptoms resolve; continue for the full 48-72 hours beyond clinical improvement 1
- For infections requiring several weeks of treatment, clinical and bacteriological follow-up may be necessary for several months after therapy cessation 1